Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2140788
                    [Title] => Indian COVID-19 vaccine 'highly efficacious': study
                    [Summary] => Covaxin, the first Covid-19 vaccine developed in India, is "highly efficacious" and presents no safety concerns, according to a study published in the Lancet on Thursday.
                    [DatePublished] => 2021-11-12 08:05:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/12/india-covaxin_2021-11-12_08-05-48_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2106410
                    [Title] => First shipment of COVID-19 vaccines for private sector arrives
                    [Summary] => The first shipment of coronavirus vaccines purchased for the private sector arrived yesterday via a Cebu Pacific flight.
                    [DatePublished] => 2021-06-18 11:37:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/06/17/sinovac-taguig_2021-06-17_08-41-39171_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2092520
                    [Title] => India’s Covaxin hails Philippines' stamp on COVID-19 vaccine
                    [Summary] => (As released) Covaxin received Emergency Use Approval from the Philippine Food and Drug Administration, conditional on its submission of Good Manufacturing Practices certification from any country that is a member of the Pharmaceutical Inspection Cooperation Scheme.
                    [DatePublished] => 2021-04-20 16:41:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Biz Memos
                    [SectionUrl] => biz-memos
                    [URL] => https://media.philstar.com/photos/2021/04/20/covaxin-agence-france-presse_2021-04-20_18-00-06_thumbnail.jpg
                )

        )

)

COVAXIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2140788
                    [Title] => Indian COVID-19 vaccine 'highly efficacious': study
                    [Summary] => Covaxin, the first Covid-19 vaccine developed in India, is "highly efficacious" and presents no safety concerns, according to a study published in the Lancet on Thursday.
                    [DatePublished] => 2021-11-12 08:05:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/12/india-covaxin_2021-11-12_08-05-48_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2106410
                    [Title] => First shipment of COVID-19 vaccines for private sector arrives
                    [Summary] => The first shipment of coronavirus vaccines purchased for the private sector arrived yesterday via a Cebu Pacific flight.
                    [DatePublished] => 2021-06-18 11:37:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/06/17/sinovac-taguig_2021-06-17_08-41-39171_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2092520
                    [Title] => India’s Covaxin hails Philippines' stamp on COVID-19 vaccine
                    [Summary] => (As released) Covaxin received Emergency Use Approval from the Philippine Food and Drug Administration, conditional on its submission of Good Manufacturing Practices certification from any country that is a member of the Pharmaceutical Inspection Cooperation Scheme.
                    [DatePublished] => 2021-04-20 16:41:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Biz Memos
                    [SectionUrl] => biz-memos
                    [URL] => https://media.philstar.com/photos/2021/04/20/covaxin-agence-france-presse_2021-04-20_18-00-06_thumbnail.jpg
                )

        )

)

abtest

Indian COVID-19 vaccine 'highly efficacious': study

November 12, 2021 - 8:05am

Covaxin, the first Covid-19 vaccine developed in India, is "highly efficacious" and presents no safety concerns, according...

Health And Family

First shipment of COVID-19 vaccines for private sector arrives

June 18, 2021 - 11:37am

The first shipment of coronavirus vaccines purchased for the private sector arrived yesterday via a Cebu Pacific flight.

Business

India’s Covaxin hails Philippines' stamp on COVID-19 vaccine

April 20, 2021 - 4:41pm

(As released) Covaxin received Emergency Use Approval from the Philippine Food and Drug Administration, conditional on its...

Biz Memos